Back
Denali Therapeutics Stock Predictions
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
DNLI
Denali Therapeutics
Last Price:
$12.80
Seasonality Move:
12.15%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Denali Therapeutics Stock Forecast
-
Over the next 52 weeks, Denali Therapeutics has on average historically risen by 11% based on the past 7 years of stock performance.
-
Denali Therapeutics has risen higher in 1 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 14.29%
-
Is Denali Therapeutics Stock Undervalued?The current Denali Therapeutics [DNLI] share price is $13.74. The Score for DNLI is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
DNLI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Denali Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Denali Therapeutics has on average historically risen by 11% based on the past 7 years of stock performance.
Denali Therapeutics Stock Rating
Sell
14
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics overpriced?
-
Denali Therapeutics has risen higher in 1 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 14.29%
Denali Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
denalitherapeutics.com
52-Week Data
52-Week High:
33.33
52-Week Low:
12.05
Prediction Charts
Market Cap:
2B
Price in USD:
13.74
Volume:
3.6M
Beta:
1.63
Technical Analysis
SMA50:
18.70
SMA100:
21.28
SMA200:
23.11
52-Wk Change:
-29.1%
Stock Predictions
-
Is Denali Therapeutics stock public?Yes, Denali Therapeutics is a publicly traded company.
-
What is the Denali Therapeutics stock quote today?The Denali Therapeutics stock price is 13.74 USD today.
-
How to buy Denali Therapeutics stock online?You can buy Denali Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-14 | 15.09 | 15.15 | 15.70 | 14.99 |
| Mar-17 | 15.15 | 15.44 | 15.68 | 14.88 |
| Mar-18 | 15.24 | 14.51 | 15.24 | 14.49 |
| Mar-19 | 14.45 | 14.82 | 15.03 | 14.41 |
| Mar-20 | 14.61 | 14.61 | 14.98 | 14.59 |
| Mar-21 | 14.39 | 14.43 | 14.64 | 14.21 |
| Mar-24 | 14.71 | 14.76 | 14.82 | 14.31 |
| Mar-25 | 14.84 | 14.12 | 14.90 | 14.10 |
| Mar-26 | 14.13 | 13.81 | 14.31 | 13.67 |
| Mar-27 | 13.82 | 14.20 | 14.43 | 13.72 |
| Mar-28 | 14.14 | 14.78 | 14.84 | 14.02 |
| Mar-31 | 14.15 | 13.60 | 14.39 | 13.30 |
| Apr-1 | 13.59 | 12.29 | 13.67 | 12.05 |
| Apr-2 | 12.07 | 13.74 | 14.83 | 12.07 |
Denali Therapeutics Earnings
Denali Therapeutics Earnings Report: Per Share Denali Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Denali Therapeutics Forecast Revenue Growth
Denali Therapeutics Stock Analysis: Historical quarterly revenues per share for Denali Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.25 per share.
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.